pipette
ENEnglish

Saturation genome editing of BRCA1 across cell types improves interpretation of variant pathogenicity

Phoebe Dace, N. Forrester, Maria Zanti, Laura Cubitt, Chloé Terwagne, Megan Buckley, Elke Maria van Veen, Thomas Stuart Wilson, Paola Scaffidi, Kyriaki Michailidou, Gregory M. Findlay

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Abstract Germline pathogenic BRCA1 variants predispose women to breast and ovarian cancer. Despite accumulation of functional evidence, over half of reported single-nucleotide variants in BRCA1 lack a definitive clinical interpretation. Furthermore, the consistency of variant effects across cell types remains largely unexplored. Here we performed saturation genome editing (SGE) of BRCA1 in HAP1 cells to score 4,113 previously unassayed variants. Additionally, we developed an SGE assay in human mammary epithelial cells (HMECs), allowing comparison of effects across cell lines, drug treatments and genetic backgrounds. We identified 538 variants impacting gene function through distinct mechanisms. HAP1 function scores discriminate between known pathogenic and benign variants with near-perfect accuracy. Intriguingly, however, nearly half of HAP1 loss-of-function variants scored neutrally in HMECs. We show that discordantly scored variants are hypomorphic and confer intermediate cancer risk. Overall, this work demonstrates how performing SGE across cell models improves the functional interpretation of rare variants.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 13 de noviembre. Nature Genetics. Revista con revisión por pares.

DOI: 10.1038/s41588-026-02832-3